Blog

Stephen D. Nimer’s recent study could lead to a new combination therapy for leukemia

Photo taken from Sylvester Comprehensive Cancer Center/X

May 23, 2024, 09:19

Stephen D. Nimer’s recent study could lead to a new combination therapy for leukemia

Sylvester Comprehensive Cancer Center shared a post on X:

“Stephen D. Nimer’s recent study could lead to a new combination therapy for leukemia. Featuring Sylvester’s collaboration with first author Hidehiro Itonaga, Ph.D., and other researchers, learn how the study could inform FDA development of new treatments.”

Read further.
Source: Sylvester Comprehensive Cancer Center/X
.

cancer cancer collaboration Cancer research Cancer Therapy Advancements combination therapy FDA development Hematology Hidehiro Itonaga Leukemia leukemia treatment Medical Research new treatments OncoDaily Oncology Stephen D. Nimer Sylvester collaboration Sylvester Comprehensive Cancer Center

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers